Literature DB >> 30250922

What a dog transmissible tumor can teach us about cancer regression.

Ariberto Fassati1.   

Abstract

The canine transmissible venereal tumor (CTVT) is one of the few clonally transmissible cancers in nature and the only one that fully regresses following treatment with vincristine. The molecular signature of CTVT regression has been described in a recent paper published in Cancer Cell, revealing some fundamental insights into cancer regression.

Entities:  

Keywords:  Biology of malignant cells; CCL5; cancer; chemotherapy; dog; inflammation; regression; rejection; transmissible

Year:  2018        PMID： 30250922      PMCID： PMC6149735          DOI： 10.1080/23723556.2018.1472059

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN： 2372-3556


  10 in total

1.  Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.

Authors:  Leena Gandhi; Delvys Rodríguez-Abreu; Shirish Gadgeel; Emilio Esteban; Enriqueta Felip; Flávia De Angelis; Manuel Domine; Philip Clingan; Maximilian J Hochmair; Steven F Powell; Susanna Y-S Cheng; Helge G Bischoff; Nir Peled; Francesco Grossi; Ross R Jennens; Martin Reck; Rina Hui; Edward B Garon; Michael Boyer; Belén Rubio-Viqueira; Silvia Novello; Takayasu Kurata; Jhanelle E Gray; John Vida; Ziwen Wei; Jing Yang; Harry Raftopoulos; M Catherine Pietanza; Marina C Garassino
Journal:  N Engl J Med       Date:  2018-04-16       Impact factor: 91.245

2.  RANTES expression is a predictor of survival in stage I lung adenocarcinoma.

Authors:  Christopher J Moran; Douglas A Arenberg; Chiang-Ching Huang; Thomas J Giordano; Dafydd G Thomas; David E Misek; Guoan Chen; Mark D Iannettoni; Mark B Orringer; Samir Hanash; David G Beer
Journal:  Clin Cancer Res       Date:  2002-12       Impact factor: 12.531

Review 3.  Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies.

Authors:  Roberta Zappasodi; Taha Merghoub; Jedd D Wolchok
Journal:  Cancer Cell       Date:  2018-04-09       Impact factor: 31.743

Review 4.  The canine transmissible venereal tumor: a unique result of tumor progression.

Authors:  D Cohen
Journal:  Adv Cancer Res       Date:  1985       Impact factor: 6.242

Review 5.  Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents.

Authors:  Lorenzo Galluzzi; Aitziber Buqué; Oliver Kepp; Laurence Zitvogel; Guido Kroemer
Journal:  Cancer Cell       Date:  2015-12-14       Impact factor: 31.743

6.  Clonal origin and evolution of a transmissible cancer.

Authors:  Claudio Murgia; Jonathan K Pritchard; Su Yeon Kim; Ariberto Fassati; Robin A Weiss
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

7.  Transmissible [corrected] dog cancer genome reveals the origin and history of an ancient cell lineage.

Authors:  Elizabeth P Murchison; David C Wedge; Ludmil B Alexandrov; Beiyuan Fu; Inigo Martincorena; Zemin Ning; Jose M C Tubio; Emma I Werner; Jan Allen; Andrigo Barboza De Nardi; Edward M Donelan; Gabriele Marino; Ariberto Fassati; Peter J Campbell; Fengtang Yang; Austin Burt; Robin A Weiss; Michael R Stratton
Journal:  Science       Date:  2014-01-24       Impact factor: 47.728

Review 8.  A Sixth Modality of Infectious Disease: Contagious Cancer from Devils to Clams and Beyond.

Authors:  Michael J Metzger; Stephen P Goff
Journal:  PLoS Pathog       Date:  2016-10-27       Impact factor: 6.823

9.  Molecular Signatures of Regression of the Canine Transmissible Venereal Tumor.

Authors:  Dan Frampton; Hagen Schwenzer; Gabriele Marino; Lee M Butcher; Gabriele Pollara; Janos Kriston-Vizi; Cristina Venturini; Rachel Austin; Karina Ferreira de Castro; Robin Ketteler; Benjamin Chain; Richard A Goldstein; Robin A Weiss; Stephan Beck; Ariberto Fassati
Journal:  Cancer Cell       Date:  2018-04-09       Impact factor: 31.743

Review 10.  Testing the theory of immune selection in cancers that break the rules of transplantation.

Authors:  Ariberto Fassati; N Avrion Mitchison
Journal:  Cancer Immunol Immunother       Date:  2009-12-22       Impact factor: 6.968
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.